MJ
Therapeutic Areas
BioLineRx Pipeline
| Drug | Indication | Phase |
|---|---|---|
| APHEXDA® (motixafortide/BL-8040) | Stem Cell Mobilization for Autologous Transplantation in Multiple Myeloma | Approved |
| motixafortide (BL-8040) | Metastatic Pancreatic Adenocarcinoma | Phase 2b |
| AGI-134 | Solid Tumors | Phase 1/2a |
| BL-1210 / BL-1230 | Gastroenterology / Immunology | Pre-clinical |
Leadership Team at BioLineRx
PS
Philip Serlin
Chief Executive Officer and Chief Financial Officer
ES
Ella Sorani
Chief Development & Operations Officer
MZ
Mali Zeevi
Chief Legal & Operations Officer
SS
Stephen Squinto
Executive Chair of the Board of Directors
JA
Jack A. Khattar
Director
MK
Marlene Krauss
Director
RS
Rami Skaliter
Director
AB
Amos Bar-Shalev
Director